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Abstract
Background
Genome-wide association studies (GWAS) have identified association of com-
mon alleles with primary open-angle glaucoma (POAG) and its quantitative
endophenotypes near numerous genes. This study aims to determine whether
rare pathogenic variants in these disease-associated genes contribute to POAG.
Methods
Participants fulfilled strict inclusion criteria of advanced POAG at a young age
of diagnosis. Myocilin mutation carriers were excluded using direct sequencing.
Whole exome sequencing was performed on 187 glaucoma cases and 103 local
screened nonglaucoma controls then joint-called with exomes of 993 previously
sequenced Australian controls. GWAS-associated genes were assessed for enrich-
ment of rare predicted pathogenic variants in POAG. Significantly enriched
genes were compared against Exome Aggregation Consortium (ExAC) public
control.
Results
Eighty-six GWAS disease or trait-associated glaucoma genes were captured and
sequenced. CARD10 showed enrichment after Bonferroni correction for rare
variants in glaucoma cases (OR = 13.2, P = 6.94 9 105) with mutations iden-
tified in 4.28% of our POAG cohort compared to 0.27% in controls. CARD10
was significantly associated with optic disc parameters in previous GWAS. The
whole GWAS gene set showed no enrichment in POAG overall (OR = 1.12,
P = 0.51).
Conclusion
We report here an enrichment of rare predicted pathogenic coding variants
within a GWAS-associated locus in POAG (CARD10). These findings indicate
that both common and rare pathogenic coding variants in CARD10 may
contribute to POAG pathogenesis.
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Introduction
Globally, glaucoma is the most common cause of irre-
versible and preventable blindness and the second most
common cause of all blindness after cataract, accounting
for 8% of blindness worldwide in 2010 (Pascolini and
Mariotti 2012). The defining feature of glaucoma is an
optic neuropathy characterized by optic disc cupping with
corresponding visual field loss (Foster et al. 2002). With
early identification and intervention, mainly with intraoc-
ular pressure (IOP)-lowering therapy, vision loss is usu-
ally preventable (Leske et al. 2003). The disease
incorporates a spectrum of subtypes ranging from con-
genital to age-related, normal of raised IOP, open or
closed iridocorneal angle and primary or secondary etiol-
ogy (Kwon et al. 2009). Primary open-angle glaucoma
(POAG) is the most common disease subset and the high
IOP phenotype is predominant in Caucasian and African
ethnicities (Tham et al. 2014). While elevated IOP is the
single greatest risk factor for POAG, other associated
endophenotypes include optic disc morphology and cen-
tral corneal thickness (CCT) (Miglior et al. 2007; Jiang
et al. 2012; Hollands et al. 2013).
POAG exhibits high heritability, with family history
conferring up to a tenfold increase in disease risk, imply-
ing a genetic etiology (Wolfs et al. 1998). Several genes
with high penetrance mutations have been discovered
through family-based linkage studies (MYOC - *601652,
OPTN - *602432, TBK1 - *604834, CYP1B1 - *601771),
although collectively they account for <5% of total disease
burden in POAG (Fingert 2011). The common disease,
common variant hypothesis has been tested in POAG.
Genome-wide association studies (GWAS) suggest at least
part of the disease burden is attributable to common vari-
ants near or within a number of genes including ABCA1
(+600046) (Chen et al. 2014; Gharahkhani et al. 2014;
Hysi et al. 2014), AFAP1 (*608252) (Gharahkhani et al.
2014), ATOH7 (*609875) (Ramdas et al. 2011), CAV1-
CAV2 (*601047; *601048) (Thorleifsson et al. 2010;
Wiggs et al. 2011; Hysi et al. 2014), CDKN2B-AS1
(*613149) (Burdon et al. 2011; Nakano et al. 2012;
Osman et al. 2012), GAS7 (*603127) (Hysi et al. 2014),
GMDS (*602884) (Gharahkhani et al. 2014), PMM2
(*601785) (Chen et al. 2014), SIX1-SIX6 (*601205;
*606326) (Ramdas et al. 2011; Osman et al. 2012; Wiggs
et al. 2012), and TMCO1 (*614123) (Burdon et al. 2011;
van Koolwijk et al. 2012; Hysi et al. 2014). Some POAG
risk loci have shown significant associations with quanti-
tative traits related to the disease such as IOP, optic disc
morphology, and central corneal thickness (Lu et al.
2013; Hysi et al. 2014; Springelkamp et al. 2014). How-
ever the magnitude of odds ratios for all genome-wide
associated disease polymorphisms are less than two, even
for the strongest loci including TMCO1 (Burdon et al.
2011) and CDKN2B-AS1 (Burdon et al. 2011; Wiggs et al.
2012), with a significant proportion of normal controls
also carrying the risk alleles at associated polymorphisms
(Mackey and Hewitt 2014). Furthermore, the majority of
the GWAS signals are located in the noncoding regions of
the genome. There is as yet no clear understanding of the
mechanism of association of these noncoding polymor-
phisms with disease etiology (Manolio et al. 2009).
The exact contribution of rare variants to glaucoma is
not known. Common tagged single-nucleotide polymor-
phism (SNP) analysis at the genome level, using SNP
microarray technology cannot ascertain the burden of rare
variants due to the poor linkage disequilibrium between
common and rare variants (Siu et al. 2011). This case–
control study utilized whole exome sequencing (WES) to
investigate the degree of enrichment and proportion of
disease burden accounted for by rare pathogenic variants
in genes near common variants known to be associated
with POAG and related quantitative traits from GWAS as
this has not been adequately addressed in the literature.
Materials and Methods
This study adhered to the principles listed by the revised
Declaration of Helsinki and the Australian National
Health and Medical Research Council (NHMRC) state-
ment of ethical conduct in research involving humans.
Ethical approval was obtained from the Southern Ade-
laide and Flinders University Clinical Research Ethics
Committee. All peripheral blood samples were collected
for genomic DNA extraction as a part of the Australian
and New Zealand Registry of Advanced Glaucoma
(ANZRAG) as previously described (Souzeau et al. 2012).
Participants
Unrelated Caucasian participants with advanced glaucoma
and nonglaucoma Caucasian controls were included for the
study. All DNA samples were extracted from peripheral
blood samples, using the QIAamp DNA blood kit (Qia-
gen, Hilden, Germany) following the manufacturer’s proto-
col. Our case cohort inclusion criteria selected only
participants with the most severe disease and the youngest
age (mean = 44.4 years, SD = 10.4 years) of onset within
the ANZRAG database. For this study, participants were
included if there was glaucomatous visual field loss involv-
ing at least two of the four central fixation squares with a
pattern standard deviation of <0.5% on a reliable Hum-
phrey 24-2 field (Carl Zeiss, Dublin, CA), or a mean devia-
tion of worse than 15 dB in the worst affected eye. For
participants without formal visual field testing, their best-
corrected visual acuity had to be worse than 20/200 due to
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glaucomatous damage. Furthermore glaucomatous damage
had to also be present in the less affected eye as measured
by a reliable Humphrey 24-2 field, with corresponding neu-
roretinal rim thinning. With the ANZRAG database partici-
pants with the youngest age of diagnosis were selected for
this study. Efforts were made to ensure a comparable split
of participants with high and normal IOP. High-tension
glaucoma (HTG) was defined as having a maximum
recorded IOP of >21 mmHg. Individuals with known
MYOC mutations were excluded from this study as the
genetic cause for their POAG has already been identified.
For the local control cohort, all participants were exam-
ined to exclude glaucoma or glaucoma-related phenotypes.
Furthermore, in silico analysis included a larger unexam-
ined control cohort from the Australian Osteoporosis
Genetics Consortium (Estrada et al. 2012) (AOGC). These
controls were female participants with high or low bone
mass who were otherwise healthy by self-report.
Data acquisition
Exon capture and enrichment was performed on all glau-
coma cases and local controls with the SureSelect Human
All Exon V4 enrichment kit (Agilent, Santa Clara, CA,
USA) as per manufacturer’s protocol and enriched DNA
sequenced on a HiSeq2000 (Illumina, San Diego, CA,
USA) with paired end 100 bp reads (Macrogen Next Gen-
eration Sequencing Services). Local controls served as
both technical and phenotypic controls. Raw experimental
data were cleaned and joint-called with AOGC exome
data that were captured with Nimblegen Human Exome
Capture V2 (Roche, Basel, Switzerland) and sequenced on
the HiSeq2000 (Illumina, San Diego, CA, USA) (Univer-
sity of Queensland Centre for Clinical Genomics). FASTQ
files were aligned to human genome build hg19 with
novoalign (version 3.02.08). Duplicate reads were marked
with Picard MarkDuplicates (version 1.124). Local indel
realignment and base quality recalibration were per-
formed with GATK (McKenna et al. 2010) (version 3.2-
2). Variant calling of single-nucleotide variants and small
indels was performed with the UnifiedGenotyper module
in GATK and variant quality scores were recalibrated
according to the GATK “Best Practices Guidelines”
(DePristo et al. 2011; Van der Auwera et al. 2013). Anno-
tation of calls was performed using ANNOVAR (Wang
et al. 2010) software using refGene, SIFT, PolyPhen2
HVAR, Exome Sequencing Project (ESP), 1000 Genomes
and Exome Aggregation Consortium (ExAC) databases.
Data analysis
Using in-house UNIX scripts, only protein coding exonic
and splicing site variants were selected for analysis. Genes
were included in the list if they were reported by any
published GWAS or meta-analysis paper to be the closest
to SNPs associated with POAG or disease endophenotype
at P < 5 9 108 in any ethnicity. Quality control thresh-
old was set at a Genotype Quality (GQ) score of 20.
Focusing on the impact of rare mutations, all variants
with known minor allele frequency (MAF) of >1% in
dbSNP, 1000 genomes and ExAC were excluded.
Pathogenicity filtering removed all synonymous variants
and missense variants considered tolerated or only possi-
bly damaging by both SIFT and PolyPhen-2 HVAR, and
retained stop site, frameshift and predicted deleterious
missense mutations. Raw VCF data from the Exome
Aggregation Consortium were annotated with the ANNO-
VAR pipeline followed by variant selection using the same
in-house scripts to target only rare deleterious mutations
in the non-Finnish European subgroup to act as a larger
in silico population control. Mutation loads per gene
were calculated for the glaucoma cases, local control,
AOGC control and ExAC control cohorts by summing
the minor allele counts of all qualifying variants in the
same gene and dividing by the average number of cap-
tured alleles for those variants, thereby adjusting for cap-
ture rate. Odds ratios were generated between cases and
each control cohort separately, and Fisher’s exact test
used to calculate P-values, and Bonferroni correction
applied for multiple testing of all analyzed genes (n = 86,
threshold P = 5.81 9 104). Five sets of randomly chosen
independent groups of 86 WES-captured genes were
selected using a random number generator and analyzed
using the same protocol to act as control gene sets. This
step further strengthens the positive results by examining
the likelihood of false-positive findings.
Validation of variants
All variants within significantly associated genes were
independently validated by capillary sequencing (primers
listed in Table S1). PCRs were conducted on carrier sam-
ples using 40 ng of DNA, 10 lmol of each corresponding
forward and reverse primers, 0.5 units of HotStarTaq
DNA polymerase (Qiagen, Hilden, Germany), 2 lmol of
dNTP and PCR buffer in a 20 lL volume per reaction.
Thirty cycles were performed at an annealing temperature
of 62°C. Five lL of each PCR product was incubated with
2 lL of Shrimp Alkaline Phosphatase (Affymetrix, Santa
Clara, CA, USA) and 0.5 lL of E. coli exonuclease I (New
England BioLabs, Ipswich, MA, USA) at 37°C for 60 min.
Sequencing was carried out on the fluorescence-based
capillary electrophoresis system 3130xl Genetic Analyzer
(Life Technologies, Carlsbad, CA, USA) using BigDye
Terminator V3.1 (Life Technologies, Carlsbad, CA, USA)
according to manufacturer’s protocol.
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Results
A total of 187 unrelated participants with advanced
POAG and 103 screened nonglaucoma controls were
sequenced with whole exome capture and enrichment.
Combined with the large unscreened cohort of AOGC
controls (n = 993), the total number of controls was
1096. More participants had high-tension glaucoma
(HTG, n = 122) than normal-tension glaucoma (NTG,
n = 65). To date, 101 genes have been reported by GWAS
studies as being near SNPs that are statistically associated
with POAG, central corneal thickness, IOP or optic disc
morphology. Of these 101 genes, 86 had qualifying (MAF
<0.01 and predicted pathogenic) variants captured in
glaucoma and control cohorts in this study (Table S2).
The sequencing strategy utilized for cases and local
controls in this study yielded good read quality, coverage,
and depth. Mean percentage of mappable reads was high
at 99.4% with an average total on-target reads per sample
of 4.12 9 109 and an average depth of 73 reads per target
base. Average coverage at >109 depth was 97.9% of all
targeted exonic regions. The average numbers of coding
SNPs and indels per participant was 19,605 and 465,
respectively. AOGC controls had an average depth of 24
reads per target base and 109 coverage of 75.1%. After
filtering for rare predicted pathogenic variants only, there
was an average of 159 qualifying variants per participant.
A total of 1159 variants were within the 86 included genes
in case, local or AOGC control cohorts. There was no sig-
nificant enrichment (OR = 1.12, P = 0.51) in the total
carrier rate of qualifying variants in this gene set in glau-
coma cases (64.2%, 120 individuals) compared with local
and AOGC controls (61.5%, 648 individuals) although
there was a trend towards increased mutation load in
POAG cases (Table S3).
Four genes (CARD10, CWC27, RERE, and USP37) were
nominally enriched (uncorrected P < 0.05) in the glau-
coma cohort (Table 1). Only CARD10 (caspase recruit-
ment domain containing protein 10) remained
statistically significant after Bonferroni correction for 86
tested genes (P = 6.94 9 105, corrected P = 5.97 9
103) with an odds ratio of 13.2 (3.5–50.2). Eight out of
187 POAG cases (4.28%) carried a rare predicted patho-
genic variant in CARD10 confirmed by Sanger sequencing
(Figure S1). Comparatively, qualifying variants in
CARD10 were carried by 0.27% (3/1096) of the joint-
called controls. A total of five nonsynonymous variants in
this gene were identified in the POAG cohort with all but
one absent in the controls (Table 2). These variants were
predicted to be pathogenic by SIFT or PolyPhen2 as per
the filtering criteria. Additionally, the variants were
located in highly conserved regions, all having GERP
(Genomic Evolutionary Rate Profiling) scores of >2
(mean GERP score = 4.8). When tested against qualifying
variants in the unscreened public domain ExAC non-Fin-
nish European cohort (n = 33370) filtered with our pipe-
line, CARD10 remained significantly enriched in the
glaucoma cohort, albeit with a lower odds ratio
(OR = 3.3, P = 3.9 9 103). CARD10 variant carriers
had younger age at diagnosis (34.9 vs. 44.8 years,
P = 0.36) and higher IOP (27.4 vs. 24.8, P = 0.11) than
non-CARD10 cases, although the difference was not sta-
tistically significant due to the small number of CARD10
carriers. All eight CARD10 qualifying variants were suc-
cessfully validated in the carrier cases using capillary
sequencing (Figure S1) and submitted to ClinVar data-
base (http://www.ncbi.nlm.nih.gov/clinvar/) with acces-
sions SCV000266585–SCV000266589. Subanalyses of the
HTG and NTG cohorts with local and AOGC controls
showed significant association of CARD10 variants with
HTG subgroup (OR = 15.2, corrected P = 0.01). Five
control gene sets of 86 randomly selected genes were
examined and none contained any gene that was signifi-
cantly associated with POAG after Bonferroni correction
(Tables S4–S8).
Discussion
Genome-wide association studies have been examined for
common variants linked to POAG, NTG and various
associated endophenotypes; IOP, vertical cup-to-disc ratio
(VCDR), neuroretinal rim area, optic disc area and cen-
tral corneal thickness. Poor linkage disequilibrium exists
between common and rare variants; this has been demon-
strated experimentally (Siu et al. 2011). For this reason,
previous GWAS designs have reduced power to detect sig-
nals at single-nucleotide variants (SNVs) with MAF of
<1%. This study employed WES to patch the “gap” left
by GWAS and to explore whether rare variants (MAF
<1%) within 86 putative POAG risk loci were also
enriched within a severe POAG cohort. Although the
majority of rare variants from the 86 POAG risk loci do
Table 1. Genes at genome-wide significant associated loci that
reached nominal significance for enrichment of rare variants in the
glaucoma cohort. Mutational load represents the total allele frequency
burden of qualifying variants in each gene. Odds ratios are adjusted
for capture quality described in the Methods section. P-values are cor-
rected using Bonferroni multiple testing correction.
Gene
POAG
load (%)
Control
load (%)
Odds
ratio P-value
Corrected
P-value
CARD10 2.14 0.14 13.19 6.94 9 105 5.97 9 103
CWC27 1.34 0.14 6.89 9.47 9 103 0.81
RERE 1.60 0.23 5.49 0.0114 0.98
USP37 1.87 0.18 7.32 5.11 9 103 0.44
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not show significant enrichment in cases, the plausibility
that GWAS candidates may contribute to disease via a
common disease rare variant hypothesis has been demon-
strated by our study.
A previous candidate gene study of SIX6 reported an
enrichment of rare variants in POAG in that gene (Carnes
et al. 2014). The most prevalent variant, with a carrier
frequency of 1.6% in cases, identified by Carnes et al.
(2014) (rs146737847:G>A) was found in 1.6% of our
POAG cases, but also in 1.9% of local screened controls
and 1.6% of AOGC controls with an overall OR of 0.98.
The other three rare variants found in that study at a car-
rier frequency of 0.4% were not detected in our cases or
controls. In summary, our study found no enrichment of
rare variants in SIX6 in our POAG cases versus controls.
Genome-wide association of CARD10
SNPs near CARD10 were first found to be significantly
associated with optic disc area on GWAS in Singaporean
Asians, a result replicated in a Dutch Caucasian cohort
(Khor et al. 2011). Optic disc area is relevant in POAG as
a large optic disc is correlated with increased susceptibil-
ity to glaucoma in Caucasian populations (Healey and
Mitchell 1999). Meta-analysis of optic disc morphology
further implicated common variants in CARD10 in VCDR
but not POAG after adjustment for optic disc area
(Springelkamp et al. 2014). This result has since been
replicated in a separate case–control study in an Indian
population (Philomenadin et al. 2015). Cup-to-disc ratio
is fundamental in POAG as it is often used as a diagnos-
tic criterion due to its strong positive correlation with
disease incidence (Miglior et al. 2007; Hollands et al.
2013). The SNPs from the original GWAS linking
CARD10 to optic disc area were situated between 3262 bp
and 7204 bp upstream of CARD10 (Khor et al. 2011).
These SNPs are in strong linkage disequilibrium with all
common SNPs up to and including rs9610775, which is a
missense coding variant, p.R289Q in the CARD10 gene
with a population MAF of 13% (Fig. 1). The signal iden-
tified in the optic disc area GWAS may possibly relate to
CARD10 coding mutations. The SNPs found to be
significantly associated with VCDR on meta-analysis were
260 kb upstream of CARD10 with no linkage disequilib-
rium to the gene (Springelkamp et al. 2014). More likely,
these variants are involved in gene expression and regula-
tion. Therefore, the published GWAS data suggests that
both coding variants in CARD10 and its expression level
may contribute to optic disc pathology.
GWAS was able to highlight the association between
regulatory and common coding SNPs in CARD10 with
crucial optic disc parameters for the development of
POAG (Khor et al. 2011; Springelkamp et al. 2014;
Philomenadin et al. 2015). This study complements the
GWAS findings by implicating rare coding CARD10 vari-
ants that likely disrupt gene function, and are associated
with increased POAG risk within our cohort of advanced
glaucoma participants. Both common and rare variants
concurrently contribute to disease risk via differing mech-
anisms affecting the same gene - CARD10. Although more
HTG participants harbored rare CARD10 variants than
NTG participants, the presence of NTG CARD10 variant
carriers suggests that IOP elevation is not required for the
potential of CARD10 to cause glaucoma. No definitive
inference can be made from this discrepancy due to the
small sample size of the subcohorts. A plausible hypothe-
sis would be that the increased susceptibility to retinal
ganglion cell apoptosis in the CARD10 mutation carrying
individuals is compounded by elevated IOP to cause glau-
coma at an earlier age. The participant inclusion criteria
of this study selected exclusively for advanced glaucoma
phenotype and young age of diagnosis resulting in an
enrichment of CARD10 variant carriers that also main-
tained elevated IOP.
CARD10 function
Discovered in 2001, CARD10 functions as a signaling pro-
tein in the regulation of the NFjB (nuclear factor kappa
B) pathway via activation of membrane-bound G protein-
coupled receptors (McAllister-Lucas et al. 2001; Wang
et al. 2001). This cascade is initiated through interactions
between the N-terminal CARD domains of CARD10,
BCL10 and MALT1, which forms a CBM complex
Table 2. Qualifying CARD10 (NM_014550.3) variants captured in glaucoma cohort and controls. SIFT score <0.05 is predicted damaging.
PolyPhen2 HVAR score >0.909 is predicted damaging.
cDNA Residue SIFT PolyPhen2 POAG cases POAG freq Control freq ExAC freq
c.635G>A p.Arg212His 0.10 0.987 1 2.7 9 103 0 0
c.983C>T p.Ala328Val 0.02 0.944 3 8.0 9 103 9.1 9 104 3.6 9 103
c.1024G>A p.Val342Met 0.04 0.025 1 2.7 9 103 0 2 9 104
c.1210C>T p.Arg404Trp 0.01 0.764 1 2.7 9 103 0 1.5 9 105
c.2485C>T p.Arg829Trp 0.02 0.01 2 5.3 9 103 0 4.0 9 104
c.3081delC p.Pro1027fs 0 0 4.6 9 104 0
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(Scudiero et al. 2014). Overexpression of CARD10 has
been demonstrated in multiple human neoplasias includ-
ing bladder (Man et al. 2014), breast (Zhao et al. 2013),
colon (Miao et al. 2012), lung (Li et al. 2012), ovarian
(Xie et al. 2014), pancreatic (Du et al. 2014) and renal
cancers (Wu et al. 2013). In all cases, the overexpression
of CARD10 is associated with increased cell survival, pro-
liferation and therefore poor prognosis of cancer. The
underlying physiology appears to involve enhanced cell
cycling via NFjB facilitated up regulation of cyclin D1,
cyclin E, Bcl-2 and phosphorylated IjB (Miao et al. 2012;
Zhao et al. 2013; Xie et al. 2014). Other documented
consequences of CARD10 upregulation include leukocyte
activation (Cowan et al. 2014) and inhibition of angio-
genesis (Rau et al. 2014). Homozygous knockout of
CARD10 in mice causes nonviability through neural tube
defects (Grabiner et al. 2007). Grabiner et al. (2007) fur-
ther demonstrated that CARD10 may be required in neu-
ral crest cell survival through G protein-coupled receptor
induction of NFjB activation.
Primary open-angle glaucoma is a disease of enhanced
retinal ganglion cell apoptosis (Foster et al. 2002). The
NFjB pathway is profoundly involved in regulation of
cellular apoptosis. Traditionally, it was only thought to be
a promoter of cell survival and proliferation via down-
stream transcription of anti-apoptotic proteins. As such,
overexpression of NFjB leads to enhanced growth of
cancerous cells (Escarcega et al. 2007). However more
recent evidence in the central nervous system suggests
NFjB may also play a proapoptotic role depending on
the nature of the noxious stimuli (Kaltschmidt et al.
2005). In certain situations such as neuronal ischemia
and Parkinson’s disease, upregulation of NFjB led to
neuronal death via p53 signaling. Evidence in tumor cells
indicates that CARD10 promotes the antiapoptotic effect
of NFjB signaling. Therefore loss of function or down-
regulation of CARD10 leads to increased apoptosis, espe-
cially in mice neural crest cells (Grabiner et al. 2007).
Conversely, proapoptotic activity of NFjB signalling has
been recognized in the rat retina. NMDA (N-methyl-d-
Figure 1. Linkage disequilibrium between GWAS SNPs and common SNPs in CARD10 from HapMap CEU data showing D’ values. GWAS SNPs
are underlined. CARD10 gene location is represented by rectangle at the top. The left-most SNP rs9610775 (p.Arg289Gln) represents the
boundary of overlap between the GWAS significant LD block and the CARD10 gene.
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aspartate)-induced expression of NFjB p65 led to retinal
ganglion cell death which was ameliorated with knock-
down of p65 by antisense oligonucleotides (Kitaoka et al.
2007). Retinal ganglion cell damage from NFjB is likely
due to glial cell activation and interleukin (IL)-1b secre-
tion (Kitaoka et al. 2007). Given the intimate and com-
plex relationship between CARD10, NFjB and apoptosis,
pathogenic coding mutations in CARD10 are likely to
affect apoptosis signaling. The coding mutations identified
within the glaucoma cohort in this study have not been
previously characterized, however they may augment reti-
nal ganglion cell death via up or down-regulation of
NFjB. This distinction is important to ascertain in order
to translate these findings toward therapeutic strategies in
glaucoma management.
Strengths and limitations
A strength of this study is the enrichment of the disease
cohort with well-selected extreme disease phenotypes, and
it is the largest study to examine whole exomes of a well
matched case–control cohort of this nature in the glau-
coma field. ANZRAG is the largest collection advanced
glaucoma patients worldwide. Our controls are hypernor-
mal and have been individually examined to ensure the
absence of glaucoma. Finally, all significantly enriched
variants were confirmed via capillary sequencing thereby
eliminating the possibility of false-positive calls.
This study has some limitations which were largely
technical. Whole exome sequencing has enabled the rapid
examination of large numbers of genes at a reasonable
cost. Its advantage over microarray technology for genetic
studies lies in its ability to capture rare coding variants.
However this also introduces the challenge of variable cap-
ture. AOGC samples were sequenced on a different plat-
form with a different capture probe set to the case cohort.
Joint-calling of the two datasets was used to limit the
amount of artifact generated in silico. However, capture-
and sequencing platform-specific differences remained.
Some difference in capture rate at specific locations was
evident and translated to incomplete capture of some vari-
ants in the AOGC cohort. Adjustment for the capture rate
was performed in the calculation of odds ratios and P-
values. ExAC samples are more heterogeneous in data
acquisition compared with this study cohort. Inability to
joint-call our data with ExAC may have overestimated the
actual mutation burden in this public domain control
cohort. Hence the odds ratio between case and controls
falls considerably when ExAC data is included and may
represent an underestimation. Alternatively, incomplete
coverage of AOGC controls may have contributed to an
overestimation of the discovery odds ratio. Nevertheless, a
statistically significant difference remained between POAG
and controls in CARD10 mutational burden even with
comparison with ExAC controls.
Conclusion
Overall, the majority of genes near common variants
associated with glaucoma and its endophenotypes found
in GWAS did not show enrichment of rare variants in
POAG. Rare predicted pathogenic variants in CARD10, a
gene located near SNPs associated with optic disc area
and VCDR in genome-wide association studies, were
enriched in a cohort of advanced POAG. Further research
is required to elucidate the exact influence of mutations
in CARD10 on NFjB signaling, apoptosis, and the devel-
opment of POAG.
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